Primenenie nimesulida v terapii osteoartroza


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the epidemiology, pathogenesis, clinical manifestations and methods of pharmacological treatment of osteoarthrosis (OA). Nonsteroidal anti-inflammatory drugs (NSAIDs) occupy a special place among pharmacological treatments of OA due to their high anti-inflammatory activity, pronounced analgesic effect and good tolerability. Nimesulide, a selective cyclooxygenase-2 inhibitor, is one of the most popular and widely used NSAIDs in clinical practice.

Full Text

Restricted Access

About the authors

S. G Anikin

Email: artos2000@yandex.ru

References

  1. Lane N.E., Brandt K., Hawker G., et al. OARSIFDA initiative: defining the disease state of osteoarthritis // Osteoarthritis Cartilage. - 2011. - Vol. 19(5). - P. 478- 82.
  2. Фоломеева О.М. Амирджанова В.Н., Якушева О.Е. Анализ структуры XIII класса болезней //Рос. Ревматол. - 1998. - № 1. - С. 2-7.
  3. van Saase J.L., van Romunde L.K., Cats A., et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations // Ann. Rheum. Dis. - 1989. -Vol. 48(4). - P. 271-80.
  4. Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of comcommunity burden and current use of primary health care//Ann. Rheum. Dis. - 2001. - Vol. 60(2). -P. 91-7.
  5. Goldring M.B., Otero M. Inflammation in osteoarthritis // Curr. Opin. Rheumatol. - 2011. -Vol. 23(5). - P. 471-78.
  6. Song I.H., Althoff C.E., Hermann K.G., et al. Knee osteoarthritis. Efficacy of a new method of contrast-enhanced musculoskeletal ultrasonography in detection of synovitis in patients with knee osteoarthritis in comparison with magnetic resonance imaging // Ann. Rheum. Dis. 2008. -Vol. 67(1). - P. 19-25.
  7. Клинические рекомендации. Ревматология / Под ред. акад. РАМН Е.Л. Насонова. М., 2010. - 326 с.
  8. Zhang W., Nuki G., Moskowitz R.W., et al. OARSI recommendations for the Management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009 // Osteoarthritis Cartilage. - 2010. -Vol. 18(4). - P. 476-99.
  9. Vane S.J. Aspirin and other anti-inflammatory drugs// Thorax. - 2000. - Vol. 55 (Suppl. 2). -P. 3-9.
  10. Senna G.E., Passalacqua G., Andri G., et al. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs// Drug. Safety. - 1996. - Vol. 14. - P. 94-103.
  11. Bianchi M., Ferrario P., Balzarini P., Broggini M. Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis // J. Int. Med. Res. - 2006. - Vol. 34(4). - P. 348-54.
  12. Manicourt D.H., Bevilacqua M., Righini V., et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metallo-proteinases-3 and -13 in patients with flare-up of osteoarthritis // Drugs.- 2005. - Vol. 6(5). -P. 261-71.
  13. FahmiH., He Y., Zhang M., et al. Nimesulide reduces interleukin-1beta-induced cyclooxygenase-2 gene expression in human synovial fibroblasts // Osteoarthritis Cartilage. - 2001. - Vol. 9(4). -P. 332-40.
  14. Di Battista J.A., Fahmi H., He Y., et al. Differential regulation of interleukin-1 beta-induced cyclooxygenase -2 gene expression by nimesulide in human synovial fibroblasts // Clin. Exp. Rheumatol. - 2001. - Vol. 19(1 Suppl 22). -S3-5.
  15. Bianchi M., Broggini M., Balzarini P., et al. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib // Int. J. Clin. Pract.-2007. - Vol. 61(8). - P. 1270-77.
  16. Bevilacqua M., Devogelaer J.P., Righini V., et al. Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study// Int. J. Clin. Pract. - 2004. -Vol. 144 (Suppl.). - P. 13-9.
  17. Kullich W.C., Niksic F., Klein G. Effect of nimesulide on metalloproteinases and matrix degrada tion in osteoarthritis: a pilot clinical study // Int. J. Clin. Pract. - 2002. - Vol. 128 (Suppl.). -P. 24-9.
  18. Pochobradsky M.G., Mele G., Beretta A., Montagnani G. Post-marketing survey of nime-sulide in the short-term treatment of osteoarthritis // Drugs Exp. Clin. Res. - 1991. - Vol. 17(3). - P. 197-204.
  19. Shi W., Wang Y.M., Cheng N.N., et al. Metaanalysis on the effect and adverse reaction on patients with osteoarthritis and rheumatoid arthritis treated with non-steroidal anti-inflammatory drugs // Zhonghua Liu Xing Bing Xue Za Zhi. - 2003. - Vol. 24(11). - P. 1044-48.
  20. Kriegel W., Korff K.J., Ehrlich J.C., et al. Doubleblind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis // Int. J. Clin. Pract. - 2001. - Vol. 55(8). - P. 510-14.
  21. Zgradie I. Comparison of therapeutic efficacy of nimesulide and diclofenac in patients with degenerative joint diseases // J. Indian Med. Assoc. - 1999. - Vol. 97(4). - P. 119-23.
  22. Sharma S., Rastogi S., Gupta V., et al. Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection // Am. J. Ther. - 1999. - Vol. 6(4). - P. 191-97.
  23. Dreiser R.L., Riebenfeld D. Nimesulide in the treatment of osteoarthritis. Double-blind studies in comparison with piroxicam, ketoprofen and placebo // Drugs. -1993. - Vol. 46 (Suppl. 1). -P. 191-95.
  24. Bianchi M., Broggini M. A randomized, doubleblind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee // Drugs. - 2003. - Vol. 63 (Suppl. 1). - P. 37-46.
  25. Watson M., Brookes S.T., Faulkner A., Kirwan J. WITHDRAWN: Non-aspirin, non-steroidal antiinflammatory drugs for treating osteoarthritis of the knee // Cochrane Database Syst. Rev. -2007;(1):CD000142.
  26. Conforti A, Leone R, Moretti U, et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide:results of spontaneous reporting from a Northern Italian area // Drug Saf. - 2001. - Vol. 24(14). - P. 1081-90.
  27. Минушкин О.Н. Использование препарата Найз у больных, страдающих сочетанной патологией суставов и поражением верхних отделов желудочно-кишечного тракта // Научно-практическая ревматол. - 2003. -№ 5. - С. 72-6.
  28. Shah A.A., Thjodleifsson B., Murray F.E., et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen // Gut. - 2001. - Vol. 48(3). - P. 339-46.
  29. Laporte J.R., Ibanez L., Vidal X., et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents // Drug Saf. - 2004. - Vol. 27(6). -P. 411-20.
  30. Pilotto A., Franceschi M., Leandro G., et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastropro-tective drugs //Aging Clin. Exp. Res. - 2003. -Vol. 15(6). - P. 494-99.
  31. Castellsague J., Pisa F., Rosolen V., et al. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy// Pharmacoepidemiol. Drug Saf. - 2013. - Vol. 22(4). - P. 365-75.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies